EyePoint Pharmaceuticals, Inc. (EYPT) PT Raised to $31 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Jennifer Kim raised the price target on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) to $31.00 (from $22.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
